Ravindra W. Tejwani

Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol–polysorbate 80 mixture

Hemant Joshi, Ravindra W. Tejwani, Martha Davidovich et al. · International Journal of Pharmaceutics · 2003 · 146 citations

Poorly Water-soluble Drug, Pharmaceutical Science, Polyethylene Glycol–polysorbate 80 +6

Discovery and Development of 5-[(5<i>S</i>,9<i>R</i>)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1

Dominique Potin, Michèle Launay, Francoise Monatlik et al. · Journal of Medicinal Chemistry · 2006 · 51 citations · Full text

Recommendations for the Assessment of Blend and Content Uniformity: Modifications to Withdrawn FDA Draft Stratified Sampling Guidance

Thomas García, James Bergum, James Prescott et al. · Journal of Pharmaceutical Innovation · 2014 · 40 citations

Health Policy, Bioequivalence, Sample Treatment +6

DRUG DISCOVERY INTERFACE: Functional Group Dependence of Solute Partitioning to Various Locations within a DOPC Bilayer: A Comparison of Molecular Dynamics Simulations with Experiment

Ravindra W. Tejwani, Malcolm E. Davis, Bradley D. Anderson et al. · Journal of Pharmaceutical Sciences · 2011 · 30 citations

Engineering, Solute Partitioning, Medicine +9

Study of Phase Behavior of Poly(ethylene glycol)–Polysorbate 80 and Poly(ethylene glycol)–Polysorbate 80–Water Mixtures

Ravindra W. Tejwani, Hemant Joshi, Sailesh A. Varia et al. · Journal of Pharmaceutical Sciences · 2000 · 29 citations

Materials Science, Chemical Engineering, Ethylene Glycol +10